Andrew Davies (@AndyD1036) profile picture

Lymphoma Doc. Improving outcomes for patients

Joined June 2022
Thoughtful @JCO_ASCO editorial on Treatment of Hodgkin Lymphoma in Older Patients: "N-AVD should become the new standard...BrECADD is an alternative in very fit older adults where response-adapted treatment would be appropriate." ascopubs.org/doi/full/10.120…
1
15
37
3,804
We’re bringing the UK's leading lymphoma experts straight to your screen for #LymphomaManagement 2025. Are you a registrar, consultant, specialist nurse, pharmacist or other healthcare professional? Register now 👉 lymphoma-action.org.uk/event… #LymSM #Lymphoma @tobyeyre82 @graham74GC
7
13
1,621
📢⏳📃 Final call for abstracts for the #17ICML! Submissions are due tomorrow by 17:59 CET. 🔗Submit your abstract here: myaccount.icml.ch/login #lymphoma #lymsm #CLL #myeloma @AACR
5
8
1,432
Davies et al ash.confex.com/ash/2022/webp… RCT for ABC (by GEP) DLBCL, Bortezomib+RCHOP21 associated with ⬆️PFS Also ⬆️OS intriguingly, however not powered for OS: thelancet.com/action/showPdf… Looking fwd to this presentation at #ASH22 #lymsm @graham74GC @AndyD1036 @ASH_hematology
7
18
2
72